Holistic Care Approach Helps Patients With Severe Obesity
A multidisciplinary, personalized weight loss plan including semaglutide, dietary counseling, and physical therapy helped a patient with severe obesity.
Read MoreMay 15, 2025
A multidisciplinary, personalized weight loss plan including semaglutide, dietary counseling, and physical therapy helped a patient with severe obesity.
Read MoreMay 15, 2025
Researchers at the AACE Annual Meeting 2025 found that educating patients to use a diet self-monitoring mobile app improved adherence to a weight loss program.
Read MoreMay 13, 2025
Patients with inflammatory disorders and acute heart failure experienced more cardiovascular complications despite similar in-hospital mortality.
Read MoreMay 13, 2025
The annual Peripheral Nerve Society meeting will include a series of mini-symposia on Charcot-Marie-Tooth Disease, peripheral nerve repair, and more.
Read MoreMay 13, 2025
Forthcoming highlights of the annual meeting of the Peripheral Nerve Society include eight special lectures, including the closing keynote.
Read MoreMay 6, 2025
A new consensus redefines obesity as a chronic illness and urges better diagnostics, equitable care, and stigma-free, evidence-based interventions.
Read MoreMay 2, 2025
The HOST-BR trial found that a 3-month dual antiplatelet therapy regimen after percutaneous coronary intervention balances ischemic and bleeding risks.
Read MoreMay 2, 2025
Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase 2b Advance-HTN trial.
Read MoreApr 30, 2025
The REVERSE-IT trial showed bentracimab effectively reversed the effects of ticagrelor, restoring platelet function with minimal side effects.
Read MoreApr 30, 2025
New research presented at ACC.25 suggests that intensive blood pressure control reduces cardiovascular events and mortality in patients with hypertension.
Read MoreApr 23, 2025
Research presented at the 2025 AAD Annual Meeting showed that moderate to severe scalp psoriasis was associated with a substantial impact on quality of life.
Read MoreApr 9, 2025
Study demonstrates that stable BTT patients with second-generation VADs (I5.5) can be safely transitioned from ICU to step-down units, alleviating ICU congestion and providing significant financial benefits.
Read MoreApr 9, 2025
Researchers called for dermatologists to recognize psoriasis-associated comorbidities, which can be managed more effectively with a multidisciplinary care team.
Read MoreApr 1, 2025
Collaborating with patients is essential for addressing sleep disturbances and mental health comorbidities, which are under-recognized in psoriasis.
Read MoreApr 1, 2025
ESK-001, a TYK2 inhibitor, showed promising efficacy and good tolerability in phase 2 for plaque psoriasis, prompting a phase 3 trial.
Read MoreApr 1, 2025
Patients with melanoma and cIRAEs on immune checkpoint inhibitors face higher toxicity risks but improved survival, warranting close monitoring.
Read MoreApr 1, 2025
Bempikibart demonstrated durable, clinically meaningful responses in patients with severe alopecia areata in the phase 2 SIGNAL-AA trial.
Read MoreApr 1, 2025
A recently developed treatment satisfaction tool called the DermSat-7 was valid and reliable for use in psoriasis management and clinical trials.
Read MoreMar 27, 2025
Research presented at ACC.25 focused on coordination teams and new hospital workflows designed to improve referrals and care quality for cardiology patients.
Read MoreMar 26, 2025
A digital monitoring program reduced readmission rates and bolstered cardiac rehabilitation enrollment among patients with coronary heart disease.
Read More